Skip to main content
Epocrates Online
Contact us
Explore features
Reach clinicians
Buy now
By
vgreene
, 26 March, 2021
Anticoagulation can be considered in pts w this level of risk
By
vgreene
, 26 March, 2021
Other considerations1
By
vgreene
, 26 March, 2021
Duration extended
By
vgreene
, 26 March, 2021
Range 2 0 3 0
By
vgreene
, 26 March, 2021
Target INR 2 5
By
vgreene
, 26 March, 2021
Tx recommendations1
By
vgreene
, 26 March, 2021
Related resource AFib Outpatient Mgmt epocrates Guideline Synthesis
By
vgreene
, 26 March, 2021
Reasonable to omit anticoagulation
By
vgreene
, 26 March, 2021
Other considerations1
By
vgreene
, 26 March, 2021
Duration n a
Pagination
First page
Previous page
…
Page
1129
Page
1130
Page
1131
Page
1132
Current page
1133
Page
1134
Page
1135
Page
1136
Page
1137
…
Next page
Last page
About Us
Company Overview
Media Relations
Contact
Editorial Policy
Editorial Process
Third-Party Sponsorship Policy
athenahealth
Products
Core Products
Mobile CME
Product Licenses
Business Solutions
Pharma
Market Research
Institutions
Support
Support Center
Install
My Account
Stay Connected
Facebook
Twitter
YouTube
